Treatment Outcome and Mortality Among Geriatric Patients Diagnosed with Multiple-Drug Resistant Tuberculosis: A Comparative Analysis from a Tertiary Referral Center
- 1 November 2021
- journal article
- research article
- Published by Galenos Yayinevi in Medical Bulletin of Haseki
- Vol. 59 (5), 377-380
- https://doi.org/10.4274/haseki.galenos.2021.7596
Abstract
Aim: Multidrug-resistant (MDR) tuberculosis (TB) and drug-sensitive-TB have long treatment periods which affect patient compliance and treatment outcomes. We planned to determine the factors that will affect the management of this disease in the elderly population. Methods: In a period of two years, a total of 82 elderly patients with bacteriologically proven TB enrolled into our retrospective study between 2011-2018. The patients' demographic features, laboratory findings, and hospital records were analyzed. Results: We enrolled 67 (87.7%) patients with drug-sensitive TB and 15 (18.2%) MDR-TB in our study. In the study population, 73.2% (n=60) were male and the mean age was 75 +/- 9 years. When we compare treatment complications of MDR-TB and drug-sensitive-TB, we found out the rate of electrolyte imbalance, nephrotoxicity, and ocular toxicity more common among the MDR-TB group (p=0.008, p=0.008, and p=0.032, respectively). When we compare the mortality rate, cure, and treatment success between MDR-TB and drug sensitive TB, there were no statistically significant results (p=0.898, p=0.549, p=0.488; respectively). Conclusion: However, we think that this was due to the low sample size. Nevertheless, we should be careful in terms of complications management of the geriatric population.Keywords
This publication has 13 references indexed in Scilit:
- Recent updates on drug resistance in Mycobacterium tuberculosisJournal of Applied Microbiology, 2019
- Determinants of mortality in elderly patients with tuberculosis: a population-based follow-up studyEpidemiology and Infection, 2017
- Does tuberculosis threaten our ageing populations?BMC Infectious Diseases, 2016
- Cost of tuberculosis in the era of multidrug resistance: will it become unaffordable?European Respiratory Journal, 2012
- Tuberculosis: cost of illness in GermanyEuropean Respiratory Journal, 2012
- Tuberculosis in Older Adults in the United States, 1993-2008Journal of the American Geriatrics Society, 2011
- Tuberculosis at extremes of ageRespirology, 2010
- Age and the epidemiology and pathogenesis of tuberculosisThe Lancet, 2010
- Diabetic Control and Risk of Tuberculosis: A Cohort StudyAmerican Journal of Epidemiology, 2008
- A systematic review of delay in the diagnosis and treatment of tuberculosisBMC Public Health, 2008